98%
921
2 minutes
20
Objective: To characterize the use of portal venous or delayed phase CT as an alternative to estimate washout for the non-invasive diagnosis of hepatocellular carcinoma (HCC) on gadoxetic acid-enhanced MRI in combination with other features.
Methods: This retrospective study included 226 observations ( = 162 patients) at high risk for HCC imaged with gadoxetic acid-enhanced MRI and enhanced liver CT between March 2015 and March 2018. Two radiologists independently evaluated two sets of images and assigned the final Liver Imaging Reporting and Data System (LI-RADS) categories by consensus using gadoxetic acid-enhanced MRI. LR-1, LR-2, LR-5, and LR-M were excluded from the study.The observations were divided using different criteria for washout: hypointensity on the portal venous phase (PVP) at MRI (criteria 1), hypointensity on PVP at MRI and/or hypoattenuation on the PVP/delayed phase at dynamic CT (criteria 2), and hypointensity on the PVP and/or hepatobiliary phase at MRI (criteria 3). The sensitivity, specificity, and accuracy for the diagnosis of HCC were analyzed for each criterion.
Results: Using gadoxetic acid-enhanced, 226 lesions were diagnosed as LR-3 or LR-4 by LI-RADS. Among them, 98 and 152 had "washout" at criteria 1 and 2, respectively. For the diagnosis of HCC, criteria 2 and 3 showed significantly higher sensitivities (67.3 and 92.5%, respectively) compared with criteria 1 (35.5%) ( < 0.001). The specificity of criteria 3 (13%) was significantly lower than those of criteria 1 and 2 (40.7% and 38.4%, respectively, < 0.001). The specificities between criteria 1 and 2 were not statistically different ( = 0.427).
Conclusion: Although the LI-RADS lexicon does not permit the interchange of image features among various image modalities, the sensitivity of HCC diagnosis could be improved without any decrease in specificity by adding CT image washout features.
Advances In Knowledge: Although the LI-RADS lexicon does not permit the interchange of image features among various image modalities, complementary use of dynamic CT in LR-3 or LR-4 categories on the basis of gadoxetic acid-enhanced MRI may contribute to major imaging feature.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9153718 | PMC |
http://dx.doi.org/10.1259/bjr.20210738 | DOI Listing |
Diagn Interv Radiol
September 2025
Department of Internal Medicine, Biomedical Research Institute, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Korea.
Purpose: To evaluate the feasibility of abbreviated liver magnetic resonance imaging (AMRI) with a second-shot arterial phase (SSAP) image for the viability of treated hepatocellular carcinoma (HCC) after non-radiation locoregional therapy (LRT).
Methods: We retrospectively enrolled patients with non-radiation LRT for HCC who underwent the modified gadoxetic acid-enhanced liver MRI protocol, which includes routine dynamic and SSAP imaging after the first and second injection of gadoxetic acid, respectively (6 mL and 4 mL, respectively), and an available reference standard for tumor viability in the treated HCC between March 2021 and February 2022. Two radiologists independently reviewed the full-protocol MRI (FP-MRI) and AMRI with SSAP.
Magn Reson Med
September 2025
Department of Biomedical Engineering, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Purpose: Gadoxetic acid-enhanced hepatobiliary phase T-weighted (Tw) MRI is effective for the detection of focal liver lesions but lacks sufficient T contrast to distinguish benign from malignant lesions. Although the addition of T, diffusion, and dynamic contrast-enhanced Tw imaging improves lesion characterization, these methods often do not provide adequate spatial resolution to identify subcentimeter lesions. This work proposes a high-resolution, volumetric, free-breathing liver MRI method that produces colocalized fat-suppressed, variable Tw images from a single acquisition, thereby improving both lesion detection and characterization.
View Article and Find Full Text PDFEur J Radiol
August 2025
Department of Medical Ultrasonics, The Eighth Affiliated Hospital of Sun Yat-sen University, No.3025 Shennan Middle Road, Shenzhen 518033, China. Electronic address:
Purpose: To investigate the predictive value of preoperative gadoxetic acid-enhanced quantitative golden-angle radial sparse parallel (GRASP) dynamic MRI for microvascular invasion (MVI) status in hepatocellular carcinoma (HCC).
Methods: This single-institution prospective study included patients with suspected HCC who underwent gadoxetic acid-enhanced GRASP dynamic MRI. Quantitative parameters derived from dynamic MRI of tumor and peritumoral regions, along with clinical and conventional radiological features, were collected.
Kaohsiung J Med Sci
September 2025
Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City, Taiwan.
Hepatocellular carcinoma (HCC) surveillance with semi-annual ultrasound (US) is recommended for high-risk patients. This study investigates the impact of hepatobiliary abbreviated magnetic resonance imaging (AMRI) performed annually on the recommended US surveillance. Patients with compensated liver cirrhosis at regular HCC surveillance using US and alpha-fetoprotein, with adequate renal function and without HCC diagnosis, were enrolled.
View Article and Find Full Text PDFEur J Radiol
August 2025
Departments of Clinical Radiology, Graduate School of Medical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
Objectives: To investigate whether warming gadoxetic acid affects the frequency and degree of artifacts in the arterial phase of MRI.
Methods: This prospective study included patients who underwent gadoxetic acid-enhanced MRI (April 2016-November 2017 and June-November 2018) at a single center. Either warmed (37 °C, n = 134) or non-warmed (24 °C, n = 137) gadoxetic acid was intravenously injected at a dose of 0.